TROYEXO
Live / Applied — First extension granted (statement of use) (as of 16 Jul 2025)
What this means for you
Not registered yet, but its 07 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98395473
- Mark type
- Word mark
- Filed
- 07 Feb 2024
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Alexander Farrell
Goods and services
- Class 005 — Pharmaceuticals: Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicines for the treatment of cancer, immune therapies, and degenerative disease for human purposes; Biological preparations for the treatment of cancer, immune therapies, and degenerative disease; Pharmaceutical preparations for cancer treatments, immune therapies, and degenerative disease
Owner
- Shine-On BioMedical Co., Ltd., Taichung City, TW
- Shine-On BioMedical Co., Ltd., Taichung City, TW
Prosecution history
- 05 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 1 GRANTED
- 16 Jul 2025 — SOU EXTENSION 1 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Sept 2024 — NON-FINAL ACTION E-MAILED